Randomized prospective studies on metabolic effects of oral contraceptives.
D000328:Adult; D001779:Blood Coagulation Factors / Q000032:analysis*; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000494:pharmacology*; D003277:Contraceptives, Oral, Combined / Q000494:pharmacology*; D003280:Contraceptives, Oral, Synthetic / Q000494:pharmacology*; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D016912:Levonorgestrel; D008055:Lipids / Q000097:blood*; D009644:Norgestrel / Q000494:pharmacology; D011446:Prospective Studies; D011897:Random Allocation; D012084:Renin-Angiotensin System / Q000187:drug effects
D001779:Blood Coagulation Factors; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003280:Contraceptives, Oral, Synthetic; D008055:Lipids; D009644:Norgestrel; D004997:Ethinyl Estradiol; D016912:Levonorgestrel